ProCE Banner Activity

HER2-Positive Metastatic Breast Cancer: Current Status and Promising Agents on the Horizon

Slideset Download
Get up to date on optimal management of HER2-positive MBC with these expert-authored slides covering the latest data on HER2-directed TKIs, antibody–drug conjugates, and re-engineered antibodies.

Released: April 13, 2020

Expiration: April 12, 2021

Share

Faculty

Adam M. Brufsky

Adam M. Brufsky, MD, PhD

Associate Professor
Department of Medicine, Division of Hematology/Oncology
University of Pittsburgh
Pittsburgh, Pennsylvania

Provided by

Provided by Clinical Care Options, LLC
ProCE Banner

Supporters

Supported by educational grants from

Daiichi Sankyo, Inc.

Puma Biotechnology, Inc.

Seagen

Faculty Disclosure

Primary Author

Adam M. Brufsky, MD, PhD

Associate Professor
Department of Medicine, Division of Hematology/Oncology
University of Pittsburgh
Pittsburgh, Pennsylvania